Proton-Coupled Electron Transfer Reactions at a Heme-Propionate in an Iron-Protoporphyrin-IX Model Compound by Warren, Jeffrey J. & Mayer, James M.
Published: April 27, 2011
r 2011 American Chemical Society 8544 dx.doi.org/10.1021/ja201663p | J. Am. Chem. Soc. 2011, 133, 8544–8551
ARTICLE
pubs.acs.org/JACS
Proton-Coupled Electron Transfer Reactions at a Heme-Propionate
in an Iron-Protoporphyrin-IX Model Compound
Jeffrey J. Warren*,† and James M. Mayer*,‡
†Beckman Institute, California Institute of Technology, MC 139-74, Pasadena, California 91125-0001, United States
‡Department of Chemistry, University of Washington, Box 351700, Seattle, Washington 98195-1700, United States
bS Supporting Information
1. INTRODUCTION
Many reactions commonly understood as electron transfer
reactions involve protons as well as electrons. These proton-
coupled electron transfer (PCET) reactions are central to a wide
range of chemical and biochemical processes, from biosynthetic
pathways to energy transduction.1 Heme enzymes are ubiquitous
in biology and frequently utilize PCET. For instance, the catalytic
cycles of peroxidases and related enzymes involve the addition of
Hþ and e to the reactive ferryl (FedO) group to return to the
Fe(III) resting state.2 Many of the substrates of heme enzymes
react with the transfer of both Hþ and e, including dioxygen,
CH bonds, hydroquinones, and ascorbate.3 Ascorbate
(AscH) oxidation occurs by loss of 1e and 1Hþ to give the
semidehydroascorbyl radical Asc•, as in its oxidation by the
bis(histidine)-ligated heme in cytochrome b561.
4 Under physio-
logical conditions, ascorbate oxidation has been shown to occur
by transfer of 1eþ 1Hþ in a single kinetic step, termed concerted
protonelectron transfer (CPET).4,5 CPET is a common me-
chanism for many of these substrates because of the high energy
of the intermediates that would be formed on transfer of the
electron alone or the proton alone.3
In ascorbate peroxidase (APX), and in other heme enzymes,6,7
the substrate is located distant from the iron. Therefore the
proton (Hþ) lost upon AscH oxidation is transferred to a site
other than the ferryl.8,9 This contrasts with the typical mechan-
ism of ferryl active sites, such as the oxidations of unactivated
CH bonds by cytochromes P450. In the P450 catalytic cycle,
the RH substrate transfers a proton to the oxo group and an
electron to a holemostly on the heme.2 Thismechanism is typically
called hydrogen atom transfer (HAT), despite the separation of
the proton and electron in the product. X-ray crystal structures of
APX show that ascorbate binds in a pocket next to the heme,
where it is a hydrogen bond donor to the heme propionate
(Figure 1).8,9 The studies reported here indicate that the
propionate is playing the proton-accepting role in this PCET
reaction, as first suggested in a recent computational study.9 A
similar situation may occur in quinol:fumarate reductase (QFR),
the terminal enzyme in fumarate respiration. Transmembrane
electron transfer (ET) in QFR is coupled to proton transfer,
potentially by coupling ET to/from the heme-iron to proton
transfer between a heme propionate and an essential glutamate
residue in the proton transfer “e-pathway.”7 Heme-propionates
have also been implicated in the ET/proton pumping action of
cytochrome c oxidase.10 In related work, Das and Medhi have
shown that small molecule iron-protoporphyrin IX complexes
have reduction potentials that are dependent upon the proton-
ation state of the propionates.11
Described here is the first well-characterized small-molecule
model of PCET or CPET reactivity involving the heme-propio-
nate as the essential base. In these PCET reactions, redox change
occurs at the iron and proton transfer occurs at the propionate.
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the determined pKa andE1/2 values, indicate thatFe
II∼CO2H has an effective bond dissociation free energy (BDFE) of 67.8( 0.6 kcalmol1.
In these PPIX models, electron transfer occurs at the iron center and proton transfer occurs at the remote heme propionate. According to
thermochemical and other arguments, the TEMPOH reaction occurs by concerted protonelectron transfer (CPET), and a similar pathway is
indicated for the ascorbate derivative. Based on these results, heme propionates should be considered as potential key components of PCET/
CPET active sites in heme proteins.
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One example is shown to occur by concerted transfer of e and
Hþ (CPET), despite the large separation between the propio-
nate and the iron. These studies mimic some of the biological
PCET reactions above. They also complement ultrafast kinetic
studies of PCET reactions of nickel and zinc purpurins (porphyrin
derivatives) in which photoinduced electron transfer is accom-
panied by proton transfer from a conjugated amidinium group to
a hydrogen-bonded naphthalenediimide acceptor.13
2. RESULTS
2.1. Synthesis and Characterization of Compounds. In
order to have a model system in which there is only one site for
acid/base reactivity, we have prepared iron complexes with the
monomethyl ester of protoporphyrin IX (PPIXMME) and N-
methylimidazole (MeIm).14 This system is related to our re-
cently described iron-porphyrin models in which a ligated
imidazolate is the proton-accepting site.15 FeIII(PPIXMME)Cl
was synthesized as reported from hemin chloride and MeOH/
H2SO4 in THF.
16 Subsequent treatment with AgOTf in
THF, and then MeIm, yields [FeIII(PPIXMME)(MeIm)2]OTf
(abbreviated FeIII∼CO2Hþ), which has been isolated and char-
acterized. 1HNMRspectra inCD3CN show thatFe
III∼CO2Hþ is
a 1:1 mixture of isomers that differ only in which propionate was
esterified (the full spectrum is given in the Supporting In-
formation). These isomers have identical kinetic and thermo-
chemical properties to the extent that we can determine.
Spectrophotometric titrations of 2  105 M FeIII∼CO2Hþ
with the bases DBU (1,8-diazabicyclo(5.4.0)undec-7-ene) or
nBu4NOH (1 M in MeOH), show a decrease in the intensity
of the Q-band centered at 533 nm up to one equivalent of base.
The spectral changes are reversible with 1 equivalent of triflic acid
(HOTf), consistent with production of the deprotonated species
FeIII∼CO2 (eq 1; only one methyl-ester isomer is shown).
Visible spectra showing the porphyrin Q-bands for these species,
and for the ferrous derivative FeIII∼CO2Hþ, are given in
Figure 2.17 Titration with the base Et3N gives pKa(Fe
III∼CO2Hþ)
= 21.1 ( 0.3. These measurements, and all of the measurements
reported here, were done in MeCN containing 5 mMMeIm and
0.1M nBu4NPF6. The addedMeIm ensures that all of the complexes
have six-coordinate iron centers, as previously described.15 The
nBu4NPF6 is added to give the same solution conditions as those
used for the electrochemical studies; when constructing thermo-
chemical cycles such as Scheme 1 it is important to keep the
measurement conditions as similar as possible. Et3N titrations
were done either working quickly with a standard spectrophot-
ometer or, more conveniently, with stopped-flow mixing, to
avoid the slow precipitation of FeIII∼CO2 that occurs (over
1020min for (15) 105M solutions). This could be due to
formation of a dimeric species similar to β-hemeetin.18
Adding 1 equiv of cobaltocene to a solution of FeIII∼CO2H
causes the appearance of newQ-bands, indicating the production
of the iron(II) complex FeII(PPIXMME)(MeIm)2 (Fe
II∼CO2H).
The λmax and ε are in agreement with similar model complexes
19
and with ferrous, bis(histidine)-ligated cytochrome b5.
20 Cyclic
voltammograms of FeIII∼CO2Hþ in MeCN with 5 mM MeIm
and 0.1 M nBu4NPF6 show a reversible wave at0.670 ( 0.010
V versus Cp2Fe
þ/0. Addition of 1 equiv of nBu4NOH causes a
small shift of the wave to 0.690 ( 0.010 V versus Cp2Feþ/0,
which is reversed with 1 equiv of HOTf. The redox potentials,
and the small shift in E1/2 upon deprotonation of the propionate,
were also confirmed by equilibration with decamethylferrocene
(Cp*2Fe) (see Supporting Information).
The pKa and redox potential results are summarized in
Scheme 1, which provides a thermochemical map of this system.3
FeIII∼CO2 and FeII∼CO2H differ by Hþ þ e or, equivalently,
H•. The free energy for FeII∼CO2Hf FeIII∼CO2þH• is given
Figure 1. A portion of the X-ray crystal structure of APX,8a with the
ascorbate-to-propionate hydrogen bond indicated by the arrow.12.
Figure 2. Visible spectra of the Q-bands of FeIII∼CO2Hþ (black),
FeII∼CO2H (blue), and FeIII∼CO2 (red).
Scheme 1. Thermochemistry of Fe(PPIXMME) System in
MeCN
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by 1.37pKaþ 23.06E1/2þ CG = 68.4( 1.2 kcal mol1.21 This is
analogous to a homolytic bond dissociation free energy (BDFE)
although there is no formal bond homolysis of FeII∼CO2H,
since the proton is heterolytically cleaved from the carboxylate
and the electron comes from the iron center. A similar analysis
has been applied to reagents such as ferrocene-carboxylate, which
has been used as a net H-atom donor,22 and to PCET reactions
that employ separate reductant and acid reagents (or oxidant and
base reagents).3,23 From a thermodynamic perspective, all of
these “BDFEs” are equivalent.3
2.2. PCET Reactivity of FeII/III∼CO2(H). 2.2.1. Reactions with
5,6-Isopropylidene Ascorbate. The oxidized, deprotonated com-
plex FeIII∼CO2 reacts very rapidly with 5,6-isopropylidene
ascorbate (iAscH) to give a ferrous porphyrin FeII∼CO2H
and the corresponding ascorbyl radical iAsc• (eq 2). iAscH is
an MeCN soluble analog of ascorbate, with thermochemical
properties similar to those of ascorbate; the formation of the
iAsc• radical was confirmed by EPR (Supporting Information,
Figure S7).24 Optical spectra of reaction mixtures show the
quantitative formation of a ferrous porphyrin but do not distin-
guish between its protonated and deprotonated forms
(FeII∼CO2H vs FeII∼CO2, see Experimental Section). Keep-
ing track of the proton is often a challenge in PCET systems
where the redox and acid/base sites are quite separated.25 The
formation of the protonated ferrous derivative, as shown in eq 2,
is indicated by the stoichiometry of the reaction and by experi-
ments discussed below.
Stopped-flow kinetic measurements under pseudo-first-order
conditions of excess iAscH indicate that reaction 2 is first-order
in both FeIII∼CO2 and iAscH, with k2 = (7.0 ( 0.4)  104
M1 s1 at 298 K. Similar measurements with iAscD show lower
rate constants, indicating a small kinetic isotope effect (KIE), but
the pseudo-first-order k2D is not constant with [iAscD
]. This
deviation is likely due to loss of the deuterium label due to
exchange of adventitious water in the MeCN at the lower
concentrations of iAscD (<1 mM).26 Using data from experi-
ments with higher [iAscD] yields k2H/k2D = 1.2 ( 0.1, which
should be taken as theminimumKIE since some deuterium is still
being lost under these conditions. Attempts were made to ensure
high deuterium enrichment by adding millimolar D2O to the
reaction mixtures. However, this results in anomalous kinetic
behavior, possibly because the thermodynamics and kinetics of
ascorbate reactions are sensitive to the presence of hydrogen
bond donors.24b
To probe the role of the propionate, the kinetics have also
been measured for the reaction of iAscH with the protonated
and methylated iron(III) derivatives, FeIII∼CO2Hþ and [FeIII-
(protoporphyrin IX dimethyl ester)(MeIm)2]OTf [abbreviated
FeIIIPPIXDME(MeIm)2
þ]. Under the same conditions as eq 2,
these reactions proceeded only to partial completion based on
the optical spectra (Figure 2 and Supporting Information).
These observations are consistent with previous studies of PCET
reactions between iron-tetraphenyl porphyrin complexes and
iAscH.15 The data for FeIII∼CO2Hþþ iAscH can be fit using
an approach to equilibrium second-order kinetic model with k =
(2.5( 0.5) 104M1 s1 and an apparent equilibrium constant
of 0.13( 0.04. This rate constant is a factor of 3 slower than that
for FeIII∼CO2. The data for FeIIIPPIXDME(MeIm)2þþ iAscH
are essentially identical, which is reasonable since the two
systems have the same FeIII/II reduction potential (see Support-
ing Information).
The reactions of FeIII∼CO2Hþ and FeIIIPPIXDME(MeIm)2þ
with iAscH cannot be simple ET processes. Based on the
known redox potentials (Scheme 1 and ref 24a), ET from
iAscH to FeIII∼CO2Hþ is 0.26 ( 0.02 mV uphill (KET = 4
 105), inconsistent with the apparent equilibrium constant
given above. ET would generate the protonated ascorbyl radical
iAscH•, which is fairly acidic (pKa = 14 in MeCN) and would be
mostly deprotonated by the 5 mM MeIm present
(pKa(HMeIm
þ) = 12.2 in MeCN27). Thus these reactions likely
occur by iAscH donating e to FeIII and Hþ to MeIm, as shown
in eq 3. Consistent with this proposal, increasing the [MeIm]
from 0.5 to 10 mM in the reaction of iAscH þ FeIIIPPIXDME-
(MeIm)2
þ shifts the position of equilibrium more toward the
products. Assuming mass balance, the optical data indicate an
equilibrium constant for reaction 3 of K3 = (3 ( 1)  109
(ΔG3 = 11.6 ( 0.3 kcal mol1) which is in reasonable
agreement with the free energy calculated from redox potentials
and pKa values, þ10.2 ( 1.2 kcal mol1. In this case the
equilibrium constant is defined by the difference in BDFE of
iAscH and E1/2(Fe
III/IIPPIX(MeIm)2) þ pKa(MeIm) þ CG
(54.9 kcal mol1). This is an example of a ‘multiple site’ or
‘separated’ PCET/CPET reaction, as discussed in more detail in
refs 1c and 3. It should be noted that while MeIm is a strong
enough base to deprotonate iAscH•, it does not deprotonate
FeIII∼CO2Hþ to any significant extent: pKa(HMeImþ) = 12.2
vs pKa(Fe
III∼CO2Hþ) = 21.1.
FeIIIPPIXDMEðMeImÞ2þ þ iAscH þMeIm
h FeIIPPIXDMEðMeImÞ2 þ iAsc• þHMeImþ ð3Þ
The reaction of FeIII∼CO2with iAscH (eq 2) does not show
this imidazole dependence between 5 and 20 mM MeIm, which
indicates that the propionate is acting as the proton acceptor in
that case. In addition, the FeIII∼CO2þ iAscH reaction is faster
than the FeIII∼CO2Hþ þ iAscH reaction under identical
conditions. This is inconsistent with FeIII∼CO2 þ iAscH
proceeding by initial ET since the FeIII∼CO2Hþ ET reaction
is more favorable. These data all support that the propionate is
the proton acceptor in the oxidation of iAscH shown in reaction
2.
2.2.2. Reactions with the Hydroxylamine TEMPOH and Other
Hydroxylic Substrates. FeIII∼CO2 reacts rapidly with an excess
of the hydroxylamine TEMPOH (N-hydroxy-2,20-6,60-tetra-
methylpiperidine) to give the ferrous porphyrin (by visible
spectroscopy) and TEMPO (by EPR, Supporting Information,
Figure S14). In the reverse direction, FeII∼CO2H and excess
TEMPO also react rapidly, yielding FeIII∼CO2 and TEMPOH
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(by 1H NMR). Kinetic studies give the forward and reverse rate
constants k4 = 11.4 ( 1.7 M
1 s1, k4 = 4.0 ( 0.5 M
1 s1
(Figure 3). The derived equilibrium constant, k4/k4 = 2.9( 0.6,
is consistent with that from static UVvis measurements (3.1(
0.6). The agreement between these measurements confirms that
FeII∼CO2H is the product of the FeIII∼CO2 þ TEMPOH
reaction. The average value of K4 = 3.0 ( 0.6, together with
BDFE(TEMPOH) = 66.5 ( 0.5 kcal mol1,28 gives BDFE-
(FeII∼CO2H) = 67.2 ( 0.5 kcal mol1, within error of that
determined in Scheme 1. Together, these two independent
measurements give a consensus BDFE of 67.8( 0.6 kcal mol1.
The KIE for D transfer fromTEMPOD to FeIII∼CO2 (k4H/k4D)
is 3.9 ( 0.7.
FeII∼CO2H reacts with the 2,4,6-tri-tert-butyl phenoxyl radi-
cal (tBu3ArO
•) to give the corresponding phenol by 1H NMR
(eq 5). The reaction is quantitative with the stoichiometric
phenoxyl radical, consistent with the strong H-abstracting ability
of tBu3ArO
•.28 FeII∼CO2H reacts similarly with excess benzo-
quinone to give hydroquinone, and in the reverse direction,
FeIII∼CO2 plus hydroquinone yields benzoquinone (eq 6), with
an overall log K6 = 2.2 ( 0.3. The hydroquinone (H2Q)
reaction Keq and the average BDFE(H2Q) = 69 ( 2 kcal
mol13,15 give BDFE(FeII∼CO2H) = 67.5 ( 2.0 kcal mol1,
again in excellent agreement with the values derived from
Scheme 1 and from equilibration with TEMPO(H).
3. DISCUSSION
The reactions reported here—with ascorbate, TEMPO/
TEMPOH, hydroquinone/benzoquinone (H2Q/Q), and
tBu3ArO
• (eqs 2, 4, 5, and 6)—all involve net transfers of H•
by the FeIII/II∼CO2(H) model complexes (eq 7). FeII∼CO2H
is indicated to be the reduced form of the redox couple by
stoichiometry, by optical spectroscopy (which indicates the
ferrous oxidation state), and by equilibrium measurements
with TEMPO/TEMPOH and H2Q/Q starting either from
FeIII∼CO2 or FeII∼CO2H. A key role for the propionate as a
proton acceptor is indicated by the thermochemical analysis of
the TEMPOH reaction given below, and by the faster and more
complete reaction of 5,6-isopropylidene ascorbate (iAscH)with
FeIII∼CO2 versus with its protonated analog FeIII∼CO2Hþ,
even though the latter is the stronger one-electron oxidant. The
FeIII∼CO2 þ iAscH reaction is unaffected by the amount of
added N-methylimidazole (MeIm), while the analogous reac-
tions of FeIII∼CO2Hþ or FeIIIPPIXDME(MeIm)2þ are affected
because MeIm is the proton acceptor. MeIm can deprotonate the
iAscH• radical but not FeIII∼CO2Hþ. This variety of evidence for
the formation of FeII∼CO2H is important because there is no
spectroscopic evidence for a protonated carboxylate in the ferrous
product. This difficulty in keeping track of the proton is a common
challenge in studies of PCET systems in which the redox and acid/
base sites are well separated, or, more generally, when the coupling
between the redox and acid/base sites is small (see below).
While these reactions involve the net movement of net H•,
they are problematic to describe as hydrogen atom transfer
reactions because of the large separation between the iron redox
center and the carboxylate proton donor/acceptor. We have
argued that HAT reactions are best defined broadly, as the
subset of CPET reactions in which Hþ þ e (H•) are
transferred from one donor to one acceptor.3 This is in contrast
to ‘multiple-site’ CPET reactions such as XH þ base (:B) þ
oxidant (Aþ)f X• þ HBþ þ A0, for instance eq 3 above.1c,3
The reactions that interconvert FeIII∼CO2 and FeII∼CO2H
lie in between these two categories. Our group has previously
reported other PCET reactions of this type, involving ruthe-
nium complexes with a distant carboxylate.25 In the multiple-
site reactions, the base and oxidant are completely indepen-
dent; in FeII∼CO2H there is a small amount of communication
between the redox and acid/base sites. This is indicated by the
20 mV shift in the reduction potential upon protonation
(equivalently,3 a 0.3 unit change in the pKa values for the Fe
II
and FeIII complexes). As discussed below, many biochemical
PCET processes in proteins likely fall in this ‘low-coupling’
regime, such as redox-driven proton pumps.
3.1. Mechanisms of Hþ/e Transfer. In principle, all of the
PCET reactions described above could occur by proton transfer
(PT) and then electron transfer (ET); (ii) ET and then PT; or
(iii) concerted transfer of the two particles (CPET). As has been
discussed extensively elsewhere, the ground-state energetics of
these competing steps can provide powerful mechanistic
insight.29 Thus, the reaction of FeIII∼CO2 þ TEMPOH
Figure 3. Pseudo-first-order rate constants for FeIII∼CO2 þ TEM-
POH (red b), FeII∼CO2H þ TEMPO (blue 9), and FeIII∼CO2 þ
TEMPOD (red 2). The slopes of the lines give the second-order rate
constants k4, k4, and k4D, respectively.
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(eq 4) cannot occur by initial ET or by initial PT because the
ΔG for these steps, þ32 and þ27 kcal mol1, respectively, are
much larger than the observed activation barrier (ΔG‡4 = 16.0(
0.1 kcal mol1). The ΔG values are calculated from the E and
pKa values of TEMPOH
3 and FeIII∼CO2Hþ (Scheme 1), and
ΔG‡4 is calculated from the k4 and the Eyring equation. Since the
reaction cannot proceed by initial ET or PT, it therefore must
occur by concerted transfer of e and Hþ. This is the first
demonstration of a CPET reaction in which a heme-propionate
acts as the proton acceptor.
The mechanism of oxidation of ascorbate (eq 2) is not
uniquely defined by such thermochemical arguments, but a
variety of evidence suggests a CPET pathway. The obser-
ved Eyring barrier ΔG‡2 is þ10.5 ( 0.5 kcal mol1. Using
the thermochemical data of iAscH,30 initial PT to give
FeIII∼CO2Hþ and iAsc2 hasΔG2-PT =þ10.1( 0.6 kcal mol1,
and initial ET to give FeII∼CO2 þ iAscH• has ΔG2-ET = þ6.5
kcalmol1. Since both of these values are smaller thanΔG‡2, neither
stepwise pathway can be excluded based on these arguments.
Still, initial PT is unlikely because the measured barrier is only
0.3( 0.6 kcal mol1 belowΔG2/PT and PT reactions in MeCN
usually have ΔG‡ significantly greater than ΔG.31 Initial rate-
limiting ET is also unlikely because reduction of protonated
FeIII∼CO2Hþ by iAscH, which is expected to occur by ET, is ca.
three times slower than k1 despite being 20 mV more favorable.
3.2. Biochemical Implications and e/Hþ Coupling. The
oxidation of isopropylidene ascorbate by FeIII∼CO2 (reaction
2) is a model for the substrate-oxidizing step in ascorbate
peroxidase (APX, Figure 1). In reaction 2, the ascorbate is
oxidized to the radical by transfer of an electron to the iron and a
proton to the heme propionate. Ascorbate binds to APX with
formation of a hydrogen bond to a propionate, and this is the
hydrogen that is lost on oxidation. Therefore we propose that
APX follows a similar PCETmechanism, with e transfer to the
heme-iron and Hþ transfer to the propionate. PPIX-dimethy-
lester substituted APX shows loss of activity,8b which is
probably due at least in part to the blocking of the proton-
accepting site. As noted above, the rate constants for reaction of
iAscH with FeIII∼CO2Hþ or FeIIIPPIXDME(MeIm)2OTf are
slower than k2, consistent with blocking the proton accepting
group. The model reaction is not an exact mimic, since the
electron is transferred to an FeIII center in the model while the
enzymatic oxidant is an FeIVdO (ferryl) group. The mechan-
istic data indicate that the model reaction proceeds by con-
certed protonelectron transfer (CPET). This is also a likely
mechanism for APX, although the higher driving force in the
enzymatic reaction could allow a stepwise ET/PT pathway.32
Propionates have previously been suggested to play important
roles in heme-driven proton pumps4 such as those found in
cytochrome oxidase and quinol:fumarate reductase (QFR).7,10,33
Comparatively fewer reports of propionate involvement in
PCET transformations of enzyme substrates have emerged, but
a few examples are available. In nitrite reductase, for instance, the
hydroquinone substrate appears to bind to the propionate and an
axial histidine.34 This is similar to the model system reaction 6
that interconverts hydroquinone and benzoquinone. Heme
propionates may also play a role in proton and electron transfer
in the cytochrome b6f complex, which is responsible for electron
transfer between reaction centers in photosynthetic reaction
centers. The redox potentials of hemes bn and x (also known
as heme ci) in this complex are pH dependent,
35 indicating PCET
behavior, and the propionate of heme bn is hydrogen bonded to a
water molecule ligated to heme x.36 Heme x is located near the
quinone reduction site, which carries out reactions similar to
reaction 6. Nitric oxide synthase (NOS) has a hydrogen bond
between the tetrahydrobiopterin (H4B) cofactor and a heme-
propionate, and this H-bond is proposed to play a key role in the
catalytic cycle.37 It has been suggested that electron transfer from
H4B to heme is coupled to proton transfer to the propionate and
that the proton is transferred back upon reduction of the pterin.
It was proposed that this allows H4B to mediate 1e
 reactions,
and not its more common 2e chemistry.37 Based on these
examples and the model system reported here, we propose that
heme propionates may play active roles in PCET reactions in
heme proteins, in addition to their structural rules that have long
been discussed. Poulos has also commented on the variety of
both active and passive roles that heme propionates can play in
catalysis, including the effect(s) of the protonation state.38
More generally, PCET plays a perhaps underappreciated role
in the chemistry of hemes, the quintessential biological redox
cofactors. Heme proteins have a range of functions, from redox
mediators such as cytochromes c39 and b5
40 to oxidation catalysts
such as cytochromes P450 and peroxidases.2 It is well-known that
reduction of the ferryl (FedO) units in P450s and peroxidases to
the resting ferric state requires protons as well as electrons, e.g.
[FeIV(O)(PPIX•þ)]f FeIV(OH)(PPIX) in P450 and FeIV(O)-
(PPIX)f FeIII(OH)(PPIX) in peroxidases.2,41 Cytochrome b5
is typically described as an electron transfer protein, but its redox
potential is pH dependent indicating that proton movement can
accompany ET,40 but neither the propionates nor the vinyl
groups appear to be involved.42 The case for cyt b5 may be more
similar to the ascorbate reductions/oxidations of cyt b561 where
PCET may occur at an axial histidine/histidinate.
A key issue in these, and all, PCET reactions is the coupling
or communication between the proton and the electron. While
there are potentially many definitions of this coupling, the
simplest and most direct measurement is the thermodynamic
coupling. For a particular reagent, this is the shift in its pKa with
redox change or the shift in E with protonation.3 Expressed in
free energy terms, the ΔpKa and ΔE must be exactly the same
based on applying Hess’ Law to the ‘square scheme’ thermo-
chemical cycles such as Scheme 1 [ΔE = (RT/F)ΔpKa = 0.059
V  ΔpKa at 298 K].3 When the proton is transferred to an
atom directly bonded to the redox-active site, as in the ferryl
reactions, this coupling can be quite large, >1 V or >17 pKa
units.43 For the propionate model system described here, where
the proton binds to a carboxylate oxygen seven bonds removed
from the iron, the coupling is very small,ΔE = 0.02 V orΔpKa
= 0.3 (Scheme 1). A small coupling of 0.01 V has been observed
in a rigid ruthenium-terpyridyl-benzoate in which the carbox-
ylate oxygens are ten bonds and 11 Å from the Ru center.25b
The reaction of iAscH with FeIII∼CO2 proceeds by CPET
because of the stronger coupling of the e and Hþ in the ascorbate
reactant (ΔE = 0.7 V/ΔpKa = 12 for ascorbate in water3).
In sum, the coupling of redox and acid/base chemistry—the
shift in pKa upon redox change—is key to many functions of
heme cofactors. As noted above, the coupling in ferryls is large,
while the coupling is small in proton pumps driven by multiple
redox steps with small changes in free energy. The model system
described here has a small (20 mV) coupling between the
propionate and the iron center. The reactions with ascorbate
and TEMPOH occur by concerted protonelectron transfer
(CPET) because of the significant coupling of e and Hþ in the
organic substrate.
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4. CONCLUSION
A model heme system has been developed where redox
chemistry occurs at iron and acid/base chemistry occurs at a
propionate. The model complexes FeIII/II∼CO2(H) undergo
H-transfer reactions with an ascorbate analog, with TEMPO/
TEMPOH, with hydroquinone/benzoquinone and with tri-tert-
butylphenoxyl. The first two reactions occur via concerted proto-
nelectron transfer (CPET), and this is the first demonstration
of such reactivity involving a heme-propionate. Heme propio-
nates have long been understood as structural motifs in proteins
and have recently been suggested to be involved in redox
processes.44 This study indicates that heme propionate can be
directly involved in proton-coupled redox processes and that this
possibility should be considered in enzymatic reactions of heme
cofactors. The model systems in acetonitrile described here are
simpler than the enzymatic environment of a typical heme
cofactor, which may include intricate hydrogen bonding net-
works and/or water channels to bring protons to, or remove
them from, the active site. Still, when the substrate is hydrogen
bonded directly to the propionate and is thermochemically
biased to transfer both a proton and an electron, the results
reported here indicate that the heme propionate can be directly
involved in CPET. CPET occurs despite the large separation and
modest communication between the iron center and the pro-
pionate oxygen atoms; this communication or coupling is
suggested to be an important parameter in the PCET reactivity
of heme cofactors.
5. EXPERIMENTAL SECTION
5.1. General. All solutions for kinetic and equilibrium measure-
ments were prepared in a nitrogen filled glovebox. Synthetic procedures
were carried out under air at ambient temperature and pressure. Reagents
were purchased from Aldrich, with the exception of DBU (1,8-diazabicyclo-
[5.4.0]undec-7-ene, Strem) andhemin chloride (iron(III)protoporphyrin IX
chloride, Strem). Hemin was purified according to literature procedures.45
N-Methylimidazole (MeIm) was purified by vacuum distillation and was
stored under an inert atmosphere. TEMPOH21 and tBu3PhO
•46 were
prepared following literature procedures. TEMPOD was synthesized as
previously described:47 enrichment was 98 ( 1% by 1H NMR. iAscD2
was prepared by dissolving in CD3OD and removing the solvent under
reduced pressure a total of 3 times; enrichment was 98 ( 2% by 1H
NMR. Solutions of iAscH or iAscD were freshly generated from
iAscH2 or iAscD2 þ 1 equiv of DBU.24 Tetrabutylammonium hexa-
fluorophosphate (nBu4NPF6) was recrystallized 3 times from absolute
ethanol and dried in vacuo for 10 h at 100 C. DBU was stored in a N2-
filled glovebox and used as received. Et3N was freshly distilled from
CaH2, degassed, and stored in a N2-filled glovebox. Benzoquinone was
purified by vacuum sublimation, and hydroquinone was recrystallized
from acetone. Cp2Co (cobaltocene), Cp2Fe (ferrocene), and Cp*2Fe
(decamethylferrocene) were purified by vacuum sublimation to a dry
ice/acetone coldfinger.
Solvents were purchased from Fischer, and deuterated solvents were
purchased from Cambridge Isotope Laboratories. Acetonitrile was used
as received from Burdick and Jackson (low water) and was stored in an
argon pressurized stainless steel drum, plumbed directly into a glovebox.
Methylene chloride, diethyl ether, pentane, toluene, and benzene were
dried using a “Grubbs type”Seca Solvent System installed byGlassContour.48
1H NMR spectra were obtained on Bruker 300 and 500 MHz
spectrometers at 298 K. Chemical shifts are reported in ppm relative
to TMS by referencing to residual solvent. EPR spectra were collected at
ambient temperature on a Bruker E580 CW/ET EPR spectrometer
operating at X-band frequency. Electrospray ionization mass spectra
(ESI-MS) were obtained on a Bruker Esquire-LC ion trap mass spectro-
meter and reported asm/z. UV/visible spectra were collected at ambient
temperature using a Hewlett-Packard 8453 diode array spectrophot-
ometer and are reported as λmax in nm (ε, M
1 cm1). Static UVvis
kinetics were also performed on this instrument with samples thermo-
statted at 298 K. Cyclic voltammograms were collected using an E2
Epsilon electrochemical analyzer (Bioanalytical Systems); see Support-
ing Information for full details and cyclic voltammograms.
5.2. Synthesis of Compounds. 5.2.1. Iron(III)protoporphyrin IX
Monomethyl Ester Chloride (FeIII(PPIXMME)Cl). Fe
III(PPIXMME)Cl was
synthesized in 34% overall yield by modification of a literature
procedure49 as described in the Supporting Information.
5.2.2. [FeIII(PPIXMME)(MeIm)2]OTf (Fe
III∼CO2Hþ). To a THF (5 mL)
solution of FeIII(PPIXMME)Cl (0.023 g, 0.035 mmol) was added 91 mg
(0.035 mmol) of AgOTf. The solution was stirred under N2 for 3 h
followed by filtration through Celite to remove precipitated AgCl. The
solvent was removed under reduced pressure, and the resulting solution
was redissolved in 5 mL of CH2Cl2þ 15 μL ofN-methylimidazole. The
resulting red solution was stirred for 5 min at room temperature after
which Et2O was added to precipitate Fe
III(PPIXMME)(MeIm)2OTf
(FeIII∼CO2Hþ). Yield: 0.031 g (90%). The 1H NMR spectrum was
assigned by analogy to FeIII(PPIX)(imidazole)2
þ and FeIII(PPIX-
dimethylester)(imidazole)2
þ.50 There are twice as many 1H signals as
those for the reference compounds, indicating that FeIII∼CO2Hþ is a
50/50 mixture of isomers at the 6- and 7-positions. ESI-M: 712 [M 
MeIm]þ. 1H NMR (CD3CN þ 5 mM MeIm, 50/50 mixture of 2
isomers, 500MHz, Figure S1): δ 19.18 (s, 3H, porp-CH3), 19.08 (s, 3H,
porp-CH3), 18.97 (s, 3H, porp-CH3), 18.78 (s, 3H, porp-CH3), 18.10
(br s, 12H, Fe-ImN-CH3), 15.52 (s, 3H, porp-CH3), 15.14 (s, 3H, porp-
CH3), 13.11 (m, 1H, R-vinyl), 12.85 (m, 1H, R-vinyl), 12.19 (s, 3H,
porp-CH3), 11.81 (m, 1H, R-vinyl), 11.43 (s, 3H, porp-CH3), 11.36
(m, 1H, R-vinyl), 8.87 (br s, 4H, Im-H), 5.88 (s, 1H, porp-H), 5.85 (s,
1H, porp-H), 5.57 (s, 2H, porp-R-CH2), 5.51 (s, 2H, porp-R-CH2), 5.29
(s, 2H, porp-R-CH2), 5.19 (s, 2H, porp-R-CH2), 4.69 (s, 1H, porp-H),
4.66 (s, 1H, porp-H), 3.55 (s, 6H, CO2CH3), 1.47 (s, 1H, porp-H),
1.44 (s, 1H, porp-H), 1.20 (s, 1H, porp-H), 1.18 (s, 1H, porp-H), 0.93
(s, 8H, porp-β-CH2), 1.35 (d, 1H, vinyl-β-CH), 1.50 (d, 1H, vinyl-
β-CH),1.66 (d, 1H, vinyl-β-CH), 1.83 (s, 1H, vinyl-β-CH),3.42
(br s, 1H, vinyl-β-CH), 3.45 (br s, 1H, vinyl-β-CH), 3.79 (m, 2H,
vinyl-β-CH), 4.42 (br s, 1H, Im-H) ppm. One of the imidazole-CH
resonances was not observed; it could be attributed to the very broad
signal around 13 ppm or be obscured by the other resonances. Anal.
Calcd for C44H46F3FeN8O7S: C, 55.99; H, 4.91; N, 11.87. Found: C,
55.64; H, 4.87; N, 11.87.
5.2.3. Characterization of FeIIPPIXMME(MeIm)2 Species (Fe
II∼CO2H
and FeII∼CO2). FeII∼CO2H was generated by addition of 1 equiv of
Cp2Co to MeCN solutions of isolated Fe
III∼CO2Hþ in the presence of
5 mM MeIm. Additions of more than 1 equiv of Cp2Co caused no
further UVvis spectral changes, indicating 1 e reduction of the ferric
species. The starting complex could be regenerated cleanly with 1 equiv
of tri(p-tolyl)aminium (tol3N
•þ) oxidant. UVvis (MeCN), Q-bands
528 (14 000), 558 (27 000). The λmax and ε are in agreement withmodel
complexes51 and with ferrous cytochrome b5 (bis(histidine) ligated).
52
The deprotonated compound FeII∼CO2 is indistinguishable from
FeII∼CO2H by UVvis spectroscopy. Addition of up to 5 equiv of
DBU causes no change in the Soret or Q-bands. Based on the pKa
calculated from the difference in redox potentials (see text), 1 equiv of
DBU should fully deprotonate FeII∼CO2H.
5.2.4. Characterization of Deprotonated FeIIIPPIXMME(MeIm)2
(FeIII∼CO2). FeIII∼CO2 was generated by addition of 1 equiv of either
DBU (pKa = 24.3
53) or nBu4NOH (1 M in MeOH) to MeCN solu-
tions of isolated FeIII∼CO2Hþ in the presence of 5 mM MeIm. This
follows previous reports that addition of a stoichiometric base to
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bis(imidazole)-ligated hemes in the presence of excess imidazole gives
six-coordinate complexes, without displacement of imidazole by the
base.54 Generation of FeIII∼CO2 can be done by working quickly with
static UV, ormore conveniently with stopped-flowUVvis, as described
below. Addition of up to 1 equiv of excess base caused no further
UVvis spectral changes. The addition of 1 equiv of triflic acid to
solutions of FeIII∼CO2 cleanly regenerates FeIII∼CO2Hþ. The spectra
show no dependence on [MeIm] up to 20 mM (the highest concentra-
tion tested). UVvis (MeCN), Q-bands 535 (7700), 616 (3800).
5.3. Stopped-Flow Kinetics. All kinetics experiments were
carried out as previously described.15,24,25 Full details are given in the
Supporting Information.
5.4. Kinetic and Equilibrium Measurements by Stopped-
Flow. The determination of the pKa of Fe
III∼CO2Hþ, confirmation of
the redox FeIII/II∼CO2H and FeIII/II∼CO2 redox potentials by
equilibration with Cp*2Fe, and all of the kinetic studies were done using
anOLIS RSM-1000 stopped-flow rapid-scanning spectrophotometer. In
a typical procedure, a solution of FeIII∼CO2, 0.1 nBu4NPF6, and 5 mM
MeIm in MeCN was freshly generated from FeIII∼CO2Hþ and 1 equiv
of DBU and then was loaded into one syringe. The other syringe was
loaded with a similar solution of 1045 equiv of iAscH in MeCN/0.1
nBu4NPF6/5 mM MeIm. The kinetic data were analyzed using a first-
order model. Experimental details and plots are given in the Supporting
Information.
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